Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
DIAMETIB: Isotretinoin for diabetic retinopathy
2004-000972-15Phase 4Terminated
- Sponsor
- Michael Larsen
- Start
- Sep 2004
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4 trial of isotretinoin in diabetic retinopathy (DR), sponsored by Michael Larsen. Primary endpoints: Visual acuity and Visual and vascular function. Started Sep 2004; status: terminated.
02
Drugs
isotretinoin
03
Conditions
diabetic retinopathy (DR)
Beyond the preview
Go deeper on 2004-000972-15.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2004-000972-15.